Potency of antihypertensive therapy with Azilsartan on Walking Activity among Peripheral Artery Disease Patients With hypertention and Intermittent Claudication

Trial Profile

Potency of antihypertensive therapy with Azilsartan on Walking Activity among Peripheral Artery Disease Patients With hypertention and Intermittent Claudication

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2015

At a glance

  • Drugs Azilsartan (Primary) ; Amlodipine
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2015 Status changed from recruiting to discontinued, as reported by University Hospital Medical Information Network - Japan record.
    • 27 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top